IDF2022-0687 Characterization and efficacy of GNTI-122, a novel engineered regulatory T-cell therapy, for treating Type 1 Diabetes
| Autor: | Uenishi, G., Landuyt, A., Yam, J., Saikumar-Lakshmi, P., Guo, T., Kieffer-Kwon, P., Chen, T., Repic, M., Wickham, T., Mueller, K. |
|---|---|
| Zdroj: | In Diabetes Research and Clinical Practice March 2023 197 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect